Pharmacological restoration of gut barrier function in stressed neonates partially reverses long-term alterations associated with maternal separation.


Journal

Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025

Informations de publication

Date de publication:
May 2019
Historique:
received: 11 10 2018
accepted: 22 04 2019
pubmed: 31 5 2019
medline: 29 10 2019
entrez: 1 6 2019
Statut: ppublish

Résumé

Intestinal permeability plays an important role in gut-brain axis communication. Recent studies indicate that intestinal permeability increases in neonate pups during maternal separation (MS). The present study aims to determine whether pharmacological inhibition of myosin light chain kinase (MLCK), which regulates tight junction contraction and controls intestinal permeability, in stressed neonates, protects against the long-term effects of MS. Male Wistar rats were exposed to MS (3 h per day from post-natal day (PND)2 to PND14) or left undisturbed and received daily intraperitoneal injection of a MLCK inhibitor (ML-7, 5 mg/kg) or vehicle during the same period. At adulthood, emotional behaviors, corticosterone response to stress, and gut microbiota composition were analyzed. ML-7 restored gut barrier function in MS rats specifically during the neonatal period. Remarkably, ML-7 prevented MS-induced sexual reward-seeking impairment and reversed the alteration of corticosterone response to stress at adulthood. The effects of ML-7 were accompanied by the normalization of the abundance of members of Lachnospiraceae, Clostridiales, Desulfovibrio, Bacteroidales, Enterorhabdus, and Bifidobacterium in the feces of MS rats at adulthood. Altogether, our work suggests that improvement of intestinal barrier defects during development may alleviate some of the long-term effects of early-life stress and provides new insight on brain-gut axis communication in a context of stress.

Identifiants

pubmed: 31147734
doi: 10.1007/s00213-019-05252-w
pii: 10.1007/s00213-019-05252-w
doi:

Substances chimiques

Azepines 0
Naphthalenes 0
ML 7 109376-83-2
Myosin-Light-Chain Kinase EC 2.7.11.18
Corticosterone W980KJ009P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1583-1596

Références

Psychoneuroendocrinology. 2012 Sep;37(9):1369-78
pubmed: 22483040
Environ Microbiol. 2009 Aug;11(8):2112-22
pubmed: 19397676
Psychopharmacology (Berl). 2011 Mar;214(1):71-88
pubmed: 20886335
Front Behav Neurosci. 2014 May 22;8:192
pubmed: 24904343
Neuroscience. 2010 Nov 10;170(4):1179-88
pubmed: 20696216
PLoS One. 2011;6(11):e27961
pubmed: 22132181
Psychoneuroendocrinology. 2012 Nov;37(11):1885-95
pubmed: 22541937
J Pediatr Gastroenterol Nutr. 2010 Oct;51(4):418-24
pubmed: 20683204
Front Neuroendocrinol. 2003 Jul;24(3):151-80
pubmed: 14596810
Brain Struct Funct. 2018 Mar;223(2):883-895
pubmed: 29022091
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16050-5
pubmed: 21876150
Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G198-203
pubmed: 17510196
PLoS One. 2015 Oct 01;10(10):e0139721
pubmed: 26426902
Behav Brain Res. 2001 Nov 1;125(1-2):49-56
pubmed: 11682093
J Neural Transm (Vienna). 2015 May;122(5):709-19
pubmed: 25182413
Neurogastroenterol Motil. 2019 Feb;31(2):e13477
pubmed: 30284340
Biol Psychiatry. 2018 Jan 15;83(2):137-147
pubmed: 29033027
Trends Neurosci. 2013 May;36(5):305-12
pubmed: 23384445
EMBO Rep. 2015 Feb;16(2):164-77
pubmed: 25525071
Neurogastroenterol Motil. 2013 Apr;25(4):e272-82
pubmed: 23433203
Brain Behav Immun. 2015 Aug;48:165-73
pubmed: 25866195
Dev Psychobiol. 2016 May;58(4):482-91
pubmed: 26688108
J Neurochem. 2007 Jul;102(2):501-7
pubmed: 17419808
Curr Psychiatry Rep. 2004 Jun;6(3):210-5
pubmed: 15142474
Gut. 2014 Aug;63(8):1293-9
pubmed: 24153250
Neurogastroenterol Motil. 2019 May;31(5):e13556
pubmed: 30740845
Neuroscience. 2015 Dec 3;310:561-77
pubmed: 26408987
Gastroenterology. 2010 Dec;139(6):2102-2112.e1
pubmed: 20600016
J Appl Bacteriol. 1992 Jan;72(1):57-64
pubmed: 1541601
Brain Behav Immun. 2017 Oct;65:43-56
pubmed: 28512033
PLoS One. 2014 Feb 20;9(2):e88382
pubmed: 24586321
Dig Dis Sci. 2013 Jan;58(1):107-14
pubmed: 22777616
Appl Environ Microbiol. 2015 Jun;81(11):3655-62
pubmed: 25795669
Neurogastroenterol Motil. 2016 Apr;28(4):463-86
pubmed: 26556786
Neurogastroenterol Motil. 2014 Nov;26(11):1615-27
pubmed: 25251188
Clin Gastroenterol Hepatol. 2012 Apr;10(4):385-90.e1-3
pubmed: 22178460
Front Cell Neurosci. 2015 Oct 14;9:392
pubmed: 26528128
Clin Transl Gastroenterol. 2016 Oct 20;7(10):e196
pubmed: 27763627
J Psychiatr Res. 2017 Dec;95:196-207
pubmed: 28886447
Digestion. 2017;95(1):55-60
pubmed: 28052282
Semin Clin Neuropsychiatry. 2002 Apr;7(2):89-95
pubmed: 11953932
Ann N Y Acad Sci. 2012 Jul;1258:34-42
pubmed: 22731713
J Neurochem. 2010 Feb;112(4):1015-25
pubmed: 19943851
Neurogastroenterol Motil. 2011 Dec;23(12):1132-9
pubmed: 21988661
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
PLoS One. 2008 Jul 30;3(7):e2836
pubmed: 18665274
Stress. 2010 Mar;13(2):114-22
pubmed: 20214436
Adv Appl Microbiol. 2015;91:1-62
pubmed: 25911232
J Affect Disord. 2004 Oct 15;82(2):217-25
pubmed: 15488250
Compr Physiol. 2016 Mar 15;6(2):603-21
pubmed: 27065163
Am J Gastroenterol. 2008 Mar;103(3):765-74; quiz 775
pubmed: 18177446
Int J Neuropsychopharmacol. 2016 Aug 12;19(8):
pubmed: 26912607
Pediatr Res. 2007 Sep;62(3):240-5
pubmed: 17622962
Nucleic Acids Res. 2007;35(18):e120
pubmed: 17881377
Pain. 2005 Jan;113(1-2):141-7
pubmed: 15621374
Neuro Endocrinol Lett. 2008 Feb;29(1):117-24
pubmed: 18283240
Transl Psychiatry. 2016 Nov 29;6(11):e966
pubmed: 27898075
J Cell Sci. 2014 Apr 15;127(Pt 8):1840-53
pubmed: 24522189
Front Cell Neurosci. 2017 Aug 03;11:222
pubmed: 28824378
Gut. 2007 Nov;56(11):1522-8
pubmed: 17339238
Gastroenterology. 2003 Sep;125(3):795-804
pubmed: 12949725
Brain Behav Immun. 2013 Feb;28:218-26
pubmed: 23207107
Cell. 2013 Dec 19;155(7):1451-63
pubmed: 24315484
Neurogastroenterol Motil. 2014 Apr;26(4):510-20
pubmed: 24372793
Nat Commun. 2015 Jul 28;6:7735
pubmed: 26218677
Brain Res Bull. 2009 Aug 14;79(6):376-87
pubmed: 19463912
Gut. 2004 Apr;53(4):501-6
pubmed: 15016743
Rev Neurosci. 2017 Oct 26;28(7):739-749
pubmed: 28593878
World J Gastroenterol. 2016 Jun 14;22(22):5211-27
pubmed: 27298564
Nat Commun. 2017 Apr 04;8:15062
pubmed: 28375200

Auteurs

Marion Rincel (M)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Maïwenn Olier (M)

Laboratoire Toxalim, UMR 1331, University of Toulouse III (UPS), INP-EI-Purpan, INRA, Toulouse, France.

Amandine Minni (A)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Camille Monchaux de Oliveira (C)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Yann Matime (Y)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Eric Gaultier (E)

Laboratoire Toxalim, UMR 1331, University of Toulouse III (UPS), INP-EI-Purpan, INRA, Toulouse, France.

Isabelle Grit (I)

UMR 1280, Institut des maladies de l'appareil digestif, PhAN, INRA, University of Nantes, Nantes, France.

Jean-Christophe Helbling (JC)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Anna Maria Costa (AM)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Amandine Lépinay (A)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Marie-Pierre Moisan (MP)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Sophie Layé (S)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France.

Laurent Ferrier (L)

Laboratoire Toxalim, UMR 1331, University of Toulouse III (UPS), INP-EI-Purpan, INRA, Toulouse, France.

Patricia Parnet (P)

UMR 1280, Institut des maladies de l'appareil digestif, PhAN, INRA, University of Nantes, Nantes, France.

Vassilia Theodorou (V)

Laboratoire Toxalim, UMR 1331, University of Toulouse III (UPS), INP-EI-Purpan, INRA, Toulouse, France.

Muriel Darnaudéry (M)

Univ. Bordeaux, INRA, Bordeaux INP, NutriNeuro, UMR 1286, 33076, Bordeaux, France. muriel.darnaudery@u-bordeaux.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH